Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Using tissue cell culture to make a protein or polypeptide
Patent
1997-07-25
2000-01-11
Eisenschenk, Frank C.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Using tissue cell culture to make a protein or polypeptide
435 5, 435 71, 435326, 4353391, 435346, 5303871, 53038812, 53038835, 530809, C12P 2104, C12Q 170, C12N 512, C12N 524
Patent
active
060134844
ABSTRACT:
Described is a new variety of retrovirus designated HIV-3, samples of which are deposited in the European Collection of Animal Cell Cultures (ECACC) under V88060301. Further described are antigens obtained from the virus, particularly proteins p12, p16, p25 and glycoproteins gp41 and gp120 to be used in the diagnosis of ARC or AIDS caused by HIV-3. Immunogenic compositions to be used as vaccines contain an envelope glycoprotein of HIV-3 such as gp41 or gp120.
REFERENCES:
patent: 4839288 (1989-06-01), Montagnier
patent: 5066782 (1991-11-01), Montagnier et al.
patent: 5166050 (1992-11-01), Shriver
patent: 5217861 (1993-06-01), Montagnier
Franchini et al., "Genetic Analysis of a New Subgroup of Human and Simian T-lymphotropic Retroviruses: HTLV-IV, LAV-2, SBL-6669, and STLV-III.sub.AGM," AIDS Research and Human Retroviruses 23(1):11-17 (1987).
Clavel et al., "Isolation of a New Human Retrovirus from West Africa Patients with AIDS," Science 233:343-346 (1986).
Clavel et al., "Molecular Cloning and Polymorphism of the Human Immune Deficiency Virus Type 2," Nature 324(18):691-695 (1986).
Guyader et al, "Genome Organization and Transactivation of the Human Immunodeficiency Virus Type 2," Nature 326:662-669 (1987).
Hahn et al., "Relation of HTLV-4 to Simian and Human Immunodeficiency-associated viruses," Nature 330:184-186 (1987).
Fukasawa et al., "Sequence of Simian Immunodeficiency Virus from Africa Green Monkey, a New Member of the HIV/SIV Group," Nature 333(6172):457-461 (1988).
Rayfield et al., Emerging Infectious Diseases 2:209-212 (1996).
Janssens et al., AIDS 8:1012-1013 (1994).
Simon et al., AIDS 8:1628-1629 (1994).
Gurtler et al., Journal of Virology 68:1581-1585 (1994).
Vanden Haesevelde et al., Journal of Virology 68:1586-1596 (1994).
Fransen et al. 1997 Journal of Medical Virology 53 p 31-35, Jan. 1997.
Louwagie et al. 1996 Int Conf AIDS vol. 11 (1) p. 8 Abstract MO.A.162, Nov. 1996.
Buyse et al. 1996 Int Conf AIDS vol. 11 (2) p. 254 Abstract Th.A.4004, Nov. 1996.
Hoess et al. 1996 Int Conf AIDS vol. 11 (2) p. 256 Abstract Th.A.4014, Nov. 1996.
Chanh et al. 1986 Eur J Immunol. 16: 1465-1468, Jan. 1986.
De Leys Robert
Saman Eric
Van Heuverswyn Hugo
Vanderborght Bart
Eisenschenk Frank C.
Innogenetics N.V.
Zeman Mary K.
LandOfFree
HIV-3 retrovirus and its use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HIV-3 retrovirus and its use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HIV-3 retrovirus and its use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1461444